Paladin Labs Inc. & KV Pharmaceutical Company Sign Distribution For Micro-K(R) Extencaps(R) Capsules

MONTREAL, QUEBEC--(Marketwire - February 18, 2008) - Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company, today announced that it has entered into an exclusive Canadian Distribution Agreement with the KV Pharmaceutical Company (NYSE: KV) for Micro-K® Extencaps® Capsules.
MORE ON THIS TOPIC